Liraglutide as add-on to insulin therapy reduces BMI, added sugar intake in obese type 1
Victoza Reduces Body Fat, Increases Time in Range in Overweight Adults With Type 1 - DSM
Liraglutide Achieves A1C Targets More often than Sitagliptin or Exenatide when Added to Metformin in Patients with Type 2 Diabetes and a Baseline A1C <8.0% - Endocrine Practice
Liraglutide as additional treatment for type 1 diabetes in: European Journal of Endocrinology Volume 165 Issue 1 (2011)
Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology
Liraglutide plus insulin has no effect on HbA1c levels for people with type 1 diabetes, study finds - Diabetes
Comparison Of The Long-Term Effects Of Liraglutide And Glimepiride Monotherapy On Bone Mineral Density In Patients With Type 2 Diabetes - Endocrine Practice
The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes | Scientific Reports
Liraglutide in Adults with Type 2 Diabetes: Global Perspective on Safety, Efficacy and Patient Preference - Daisuke Yabe, Yutaka Seino, 2011
Simple Sells: How Diabetes Drug Victoza Challenges Amylin and Lilly's Byetta - CBS News
Diabetes mellitus Typ 1: Add-on-Therapie zu Insulin im Blick
GLP-1 Agonists Liraglutide Improved Vascular Endothelial Function in Type 2 Diabetes Rats
Liraglutide With Insulin Improves Glycemic Control in Type 1 Diabetes, Without More Hypoglycemia
Adjunct liraglutide use in people with type 1 diabetes in the St Vincent's Healthcare Group, Dublin: An Irish perspective - DiabetesontheNet
Disappointing results for liraglutide in type 1 diabetes
Victoza may benefit patients with type 1 diabetes, review suggests - Diabetes
One-year effects of liraglutide on pancreatic beta cell function and glycaemic control in Japanese type 1 diabetes with residual insulin secretion - Media Centre | EASD
JPM | Free Full-Text | Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes
Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes, the ADJUNCT ONE™ treat-to-target randomised trial - Media Centre | EASD
Victoza for People with Type 1 Diabetes?
Pharmaceuticals | Free Full-Text | Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats
Liraglutide as additional treatment for type 1 diabetes in: European Journal of Endocrinology Volume 165 Issue 1 (2011)
OP 01 Individualising the choice among GLP-1 receptor agonists - Media Centre | EASD
